Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-20

Clinical Trial Update: HIRREM for Stage 1 Primary Hypertension [NA]

View source ↗

Summary

A completed clinical trial investigating HIRREM for stage 1 primary hypertension; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HIRREM (neurotechnology-based self-regulation)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Hypertension, Blood Pressure | NA | Status: COMPLETED | Results posted: 2023-04-20